News

The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...
The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.
Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...
Neuros Medical has raised $56m to support the US commercialisation of Altius direct electrical nerve stimulation system.
ClearNote Health has secured the UK Conformity Assessed (UKCA) marking for the company's Avantect Pancreatic Cancer Test.
BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...
The UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation (PFA) for the treatment of atrial fibrillation (AF) within the NHS.
A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.
Philips has announced the expansion of its collaboration with Medtronic, focusing on advancing patient monitoring ...
MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.
The US FDA has granted 510(k) clearance to PathAI for its digital pathology image management system, AISight Dx.
Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.